Kontakt 2005, 7(1-2):133-137 | DOI: 10.32725/kont.2005.026
AnthraxBiomedicine
- 1 Jihočeská univerzita v Českých Budějovicích, Zdravotně sociální fakulta
- 2 Univerzita obrany v Hradci Králové, Fakulta vojenského zdravotnictví
Anthrax is a fatal bacterial infection, which occurs when endospores of the Bacillus anthracis penetrate into the body through one of the following three ways: by inspiration, through the skin or on ingestion. Prior to anthrax terrorist attacks in the USA in 2001, there was an only slight interest in anthrax as a dangerous human pathogen. Anthrax was considered as a veterinary problem of a rather low importance. This unconcerned attitude to anthrax was changed after terrorist actions in 2001. The number of victims was relatively low, however, in spite of this, the attacks enhanced the fear of possible large-area aerosol attack, which could be implemented by terrorists. That is why anesthesiologists and physicians involved in crisis management should have detailed knowledge of the diagnosis treatment, and prevention of anthrax. In the course of several recent years, an enormous progress was achieved in our understanding of molecular mechanisms of anthrax toxin effects. The structure of all its there components - lethal factor (LF), edema factor (EF) and protective antigen (PA) - was identified, which holds not only for the structure of their monomers but also for heptameric forms of PA. The way of the toxin endocytosis was also determined and the mechanism of the EF an LF enzymatic effect was elucidated.
Keywords: Bacillus anthracis; anthrax; anthrax toxin; mechanism of action; terrorism
Published: June 29, 2005 Show citation
References
- Abrami, L., Reig, N., van der Goot, F.G. 2005: Anthrax toxin: the long and winding road that leads to the kill. Trends Microbiol. 13(2): 72-78.
Go to original source...
Go to PubMed...
- Beyer, W. 2004: Vaccination strategies for anthrax prevention (Article in German) Berl. Munch. Tierarztl. Wochenschr. 117(11-12): 508-524.
Go to PubMed...
- Boháček, I. 1995: Sverdlovsk - antrax 1979. Vesmír 74(3): 174.
- Brookmeyer, R., Blades, N., Hugh-Jones, M., Henderson, D.A. 2001: The statistical analysis of truncated data: application to the Sverdlovsk anthrax outbreak. Biostatistics. 2 (2): 233-247
Go to original source...
Go to PubMed...
- Cymet, T.C., Kerkvliet, G.J. 2004: What is the true number of victims of the postal anthrax attack of 2001? J. Am. Osteopath. Assoc. 104(11): 452.
- Gair, R. 2005: Clinical predictors of bioterrorism-related inhalational anthrax. Lancet. 365(9455): 214-5; author reply 215.
Go to original source...
Go to PubMed...
- Hupert, N., Chege, W., Bearman, G.M., Pelzman, F.N. 2004: Antibiotics for anthrax: patient requests and physician prescribing practices during the 2001 New York City attacks. Arch. Intern. Med. 164(18): 2012-2016.
Go to original source...
Go to PubMed...
- Jacobs, M.K. 2004: The history of biologic warfare and bioterrorism. Dermatol. Clin. 22(3): 231-246.
Go to original source...
Go to PubMed...
- Kalamas, A.G. 2004: Anthrax. Anesthesiol. Clin. North America. 22(3): 533-540.
Go to original source...
Go to PubMed...
- Meselson, M., Guillemin, J., Hugh-Jones, M., Langmuir, A., Popova, I., Shelokov, A., Mogridge, J. 2004: Anthrax and bioterrorism: are we prepared? Lancet. 364(9432): 393-395
Go to original source...
Go to PubMed...
- Patočka, J., Špliňo, M. 2002a: Anthrax toxin characterization. Acta Medica (Hradec Králové). 45(1): 3-5.
Go to original source...
Go to PubMed...
- Patočka, J., Špliňo, M. 2002b: Historie "antraxového" ostrova Gruinard. Voj. zdrav. listy 71(2): 58-59.
- Patočka, J., Špliňo, M., Prymula, R., Chlibek, R. 2003: Antrax toxin: Deadly triumvirate of anthrax. ASA Newsletter; 96: 19-24.
- Schwartz, M. 2002: Cutaneous anthrax. J. Travel Med. 9(6): 333.
Go to original source...
Go to PubMed...
- Sugishima, M. 2003: Aum Shinrikyo and the Japanese law on bioterrorism. Prehospital Disaster Med. 18(3): 179-183.
Go to original source...
Go to PubMed...
- Szafraniec, S., Grzesiowski, P., Hryniewicz, W. 2004: Anthrax as a bioweapon (Article in Polish) Przegl. Lek. 61(3): 177-180.
Go to PubMed...
- Špliňo, M., Patočka, J. 2002: Prophylaxis against anthrax. Acta Medica (Hradec Králové). 45(3): 85-88.
Go to original source...
Go to PubMed...
- Tasota, F.J., Henker, R.A., Hoffman, L.A. 2002: Anthrax as a biological weapon: an old disease that poses a new threat. Crit. Care Nurse. 22 (5): 21-32, 34.
Go to original source...
Go to PubMed...
- Wenner, K.A., Kenner, J.R. 2004: Anthrax. Dermatol. Clin. 22(3): 247-256
Go to original source...
Go to PubMed...
- Woodrow, P. 2003: Anthrax: forms, symptoms and treatment. Nurs. Stand. 17(48): 33-37.
Go to original source...
Go to PubMed...
- Yampolskaya, O. 1994: The Sverdlovsk anthrax outbreak of 1979. Science. 266(5188): 1202-1208.
Go to original source...
Go to PubMed...